The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series

Stopped early

Conditions studied: Pilonidal Disease

In brief

A case series involving the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healing.

Key facts

Study ID

NCT04041037

Run by

Integra LifeSciences Corporation

People needed

2

Starts

2019-03-26

Expected to finish

2019-11-05

Last updated by the study team

2021-04-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject has a clinical diagnosis of pilonidal disease.
• Subject is being scheduled for surgical excision of pilonidal disease.
• Subject is at least 18 years of age.
• Subject is willing and able to adhere to protocol requirements and agrees to participate in the study program and comply with the study follow-up regimen.
• Subject is willing to provide written informed consent.

You may not qualify if…

• Subject has a known allergy to porcine-based materials.
• Subject is pregnant

Where it is running

• AdventHealth Tampa — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.